Deprescribing psychotropic medications in children: results of a national qualitative study. 2020

Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA erin.r.barnett@dartmouth.edu.

Prescriptions for psychotropic medications to children have risen dramatically in recent years despite few regulatory approvals and growing concerns about side effects. Government policy and numerous programmes are attempting to curb this problem. However, the perspectives of practising clinicians have not been explored. To characterise the perspectives and experiences of paediatric primary care clinicians and mental health specialists regarding overprescribing and deprescribing psychotropic medications in children. We conducted 24 semistructured interviews with clinicians representing diverse geographic regions and practice settings in the USA. Interview questions focused on clinician perspectives surrounding overprescribing and experiences with deprescribing. We transcribed audio files verbatim and verified them for accuracy. We analysed transcripts using a grounded theory approach, identifying emergent themes and developing a conceptual model using axial coding. Analysis yielded themes within four domains: social and clinical contextual factors contributing to overprescribing, opportunities for deprescribing, and facilitators and barriers to deprescribing in paediatric outpatient settings. Most participants recognised the problem of overprescribing, and they described complex clinical and social contextual factors, as well as internal and external pressures, that contribute to overprescribing. Opportunities for deprescribing included identification of high-risk medications, routine reassessment of medication needs and recognition of the broader social needs of vulnerable children. Facilitators and barriers to deprescribing were both internal (eg, providing psychoeducation to families) and external (eg, parent and child preferences) to clinicians. Our findings highlight a discrepancy between clinicians' concerns about overprescribing and a lack of resources to support deprescribing in outpatient paediatric settings. To successfully initiate deprescribing, clinicians will need practical tools and organisational supports, as well as social resources for vulnerable families.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069340 Deprescriptions Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION. Deprescribing,Deprescription
D036301 Qualitative Research Any type of research that employs nonnumeric information to explore individual or group characteristics, producing findings not arrived at by statistical procedures or other quantitative means. (Qualitative Inquiry: A Dictionary of Terms Thousand Oaks, CA: Sage Publications, 1997) Research, Qualitative
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
December 2025, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
May 2002, Journal of the American Academy of Child and Adolescent Psychiatry,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
May 2019, BMJ open,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
August 2025, Journal of the American Geriatrics Society,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
January 2015, Advances in experimental medicine and biology,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
February 2013, Journal of the American Geriatrics Society,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
September 2007, Actas espanolas de psiquiatria,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
July 2005, Journal of marital and family therapy,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
September 2023, Psychological medicine,
Erin R Barnett, and Alissa Z Trepman, and Hannah A Fuson, and Stephanie C Acquilano, and Jennifer L McLaren, and Steven Woloshin, and Joanna K Leyenaar
April 2018, Expert opinion on pharmacotherapy,
Copied contents to your clipboard!